CIC
VYGR icon

Cornercap Investment Counsel’s Voyager Therapeutics VYGR Stock Holding History

Cornercap Investment Counsel’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,937
Closed -$64K – 543
2024
Q3 		$64K Sell
10,937
-12,039
-52% -$87.5K 0.02% 502
2024
Q2 		$182K Sell
22,976
-241
-1% -$2.02K 0.03% 548
2024
Q1 		$216K Hold
23,217
– – 0.03% 556
2023
Q4 		$196K Buy
+23,217
New +$168K 0.03% 532

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornercap Investment Counsel's VYGR Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 10,937 shares — an estimated $64K sold.

Cornercap Investment Counsel first reported a position in VYGR in Q4 2023 and held it in 4 quarters. The position peaked at $216K in Q1 2024. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 10,937 Voyager Therapeutics shares in Q4 2024, an estimated $64K.
  • Cornercap Investment Counsel first reported a position in Voyager Therapeutics in Q4 2023 and held it in 4 quarters.
  • Cornercap Investment Counsel's Voyager Therapeutics position peaked at $216K in Q1 2024.
  • 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.